Skip to main content
. 2019 Feb 6;17(4):2861–2869. doi: 10.3892/etm.2019.7245

Figure 4.

Figure 4.

The impact of PKI (1422)-a selective PKA inhibitor-on the concentration of IL-1β (A) and the expression of p22 (B), GPx (C) and Cat (D) in NHA subjected to exenatide in normoglycemic conditions. Data expressed as mean ± SE. Asterisk indicates level of statistical significance: *P<0.05; **P<0.01.